Spectral Medical Inc.
EDTXF
$0.90
-$0.02-2.01%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 31.23% | 29.28% | 22.06% | 40.94% | 11.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.23% | 29.28% | 22.06% | 40.94% | 11.57% |
| Cost of Revenue | -20.87% | -14.66% | 17.23% | 59.85% | 62.34% |
| Gross Profit | 169.82% | 146.28% | 32.11% | 13.99% | -39.11% |
| SG&A Expenses | -0.21% | -0.33% | 9.78% | 3.79% | 13.96% |
| Depreciation & Amortization | -75.62% | -76.06% | 117.48% | 182.73% | 158.89% |
| Other Operating Expenses | 11.26% | -7.40% | -10.25% | -30.05% | -33.11% |
| Total Operating Expenses | -5.90% | -5.66% | 12.43% | 10.84% | 19.87% |
| Operating Income | 11.88% | 10.96% | -11.01% | -6.53% | -21.32% |
| Income Before Tax | -62.96% | -10.67% | -24.10% | 0.95% | -141.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -62.96% | -10.67% | -24.10% | 0.95% | -141.11% |
| Earnings from Discontinued Operations | 79.42% | 95.87% | 94.10% | 95.54% | 97.71% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -62.77% | -9.74% | -23.38% | 1.88% | -111.95% |
| EBIT | 11.88% | 10.96% | -11.01% | -6.53% | -21.32% |
| EBITDA | 12.10% | 11.09% | -11.01% | -6.49% | -22.06% |
| EPS Basic | -59.30% | -8.03% | -21.77% | 2.40% | -110.26% |
| Normalized Basic EPS | -72.25% | -13.09% | -26.85% | -2.83% | -138.10% |
| EPS Diluted | -59.30% | -8.03% | -21.77% | 2.40% | -110.26% |
| Normalized Diluted EPS | -72.25% | -13.09% | -26.85% | -2.83% | -138.10% |
| Average Basic Shares Outstanding | 1.82% | 1.63% | 1.33% | 0.94% | 0.82% |
| Average Diluted Shares Outstanding | 1.82% | 1.63% | 1.33% | 0.94% | 0.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |